Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
140.00    0.25 (0.18%)
Bid:
140.00
Ask:
142.00
Spread: 2.00 (1.429%)
Market Cap: £268.35m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Exercise of options and Total Voting Rights

14 Mar 2022 16:24

RNS Number : 7258E
Franchise Brands PLC
14 March 2022
Ā 

14 March 2022

Franchise Brands PLC

("Franchise Brands", the "Group" or the "Company")

Ā 

Exercise of options and Total Voting Rights

Ā 

Franchise Brands (AIM: FRAN),Ā a multi-brand international franchise business, announces the exercise of 354,465 employee optionsĀ under various of the Company's share option schemes. The options being exercised will be satisfied by the issue of 354,465 new ordinary shares of 0.5p each in the Company ("New Ordinary Shares").

Ā 

Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM. It is expected that admission of theĀ 354,465 New Ordinary Shares to trading on AIM will become effective on or aroundĀ 17 March 2022 ("Admission").

Ā 

The New Ordinary Shares will rankĀ pari passuĀ in all respects with the Company's existing ordinary shares.

Ā 

Total Voting Rights

Ā 

Upon Admission, the total number of ordinary shares of 0.5p each in the Company in issue will be 123,907,298. There are no ordinary shares held in treasury and therefore the total number of voting rights in the Company from Admission will be 123,907,298. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.Ā 

Ā 

Enquiries:

Ā 

Franchise Brands plc

+ 44 (0) 1625 813231

Stephen Hemsley, Executive Chairman

Brian Hogan, Chief Financial Officer

Julia Choudhury, Corporate Development Director

Allenby Capital LimitedĀ (Nominated Adviser and Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Liz Kirchner (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking)

Dowgate Capital LimitedĀ (Joint Broker)

+44 (0) 20 3903 7715

James Serjeant / Russell Cook / Nicholas Chambers

MHP CommunicationsĀ (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt

+44 (0) 7884 494112

franchisebrands@mhpc.com

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
IOESFUFMLEESEFD
Date   Source Headline
9th Jul 20267:00 amRNSNotice of Results
29th Jun 202610:27 amRNSHolding(s) in Company
25th Jun 202611:08 amRNSHolding(s) in Company
10th Jun 202612:41 pmRNSShare Premium Cancellation
8th Jun 20264:38 pmRNSGrant of Options to director
26th May 202612:58 pmRNSGrant of Options to director
18th May 20267:00 amRNSAppointment of new CFO & Group Delivery Director
30th Apr 20264:01 pmRNSResult of General Meeting
30th Apr 20264:00 pmRNSResult of Annual General Meeting
30th Apr 20267:00 amRNSAGM Statement and Q1 Trading Update
7th Apr 202612:29 pmRNSHolding(s) in Company
31st Mar 20265:13 pmRNSProposed Share Premium cancellation
31st Mar 20265:13 pmRNSAnnual Report and Accounts & Notice of AGM
27th Mar 20267:00 amRNSGrant of Options to directors
27th Mar 20267:00 amRNSDirectors’ dealings
26th Mar 20267:00 amRNSDirectors' dealings
25th Mar 20267:00 amRNSFinal Results
18th Mar 20267:00 amRNS-RInvestor Presentation via Investor Meet Company
11th Mar 20263:13 pmRNSHolding(s) in Company
11th Mar 20263:13 pmRNSHolding(s) in Company
5th Mar 202611:17 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSNotice of Results
2nd Mar 20262:00 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update
21st Jan 20263:00 pmRNSHolding(s) in Company
21st Jan 20262:55 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
12th Nov 20257:00 amRNSQ3 Trading Update
3rd Nov 20252:00 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSDirectors’ dealings
14th Oct 20257:00 amRNSEBT share purchase programme update
9th Oct 20253:48 pmRNSDirectors’ dealings – Replacement
9th Oct 20257:00 amRNSDirectors' dealings
1st Oct 20255:00 pmRNSDirectors’ dealings
29th Sep 20256:05 pmRNSDirectors’ dealings
23rd Sep 20252:00 pmRNSHolding(s) in Company
5th Aug 20258:46 amRNSUpdate on potential listing
31st Jul 20251:52 pmRNSGrant of Options to director
30th Jul 20257:00 amRNSInterim Results
21st Jul 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th Jul 20257:00 amRNSNotice of Interim Results
23rd Jun 20257:00 amRNS-RInclusion in FTSE AIM UK 50 Index
28th May 202511:06 amRNSHolding(s) in Company
19th May 20257:00 amRNSMove to SETS
7th May 20253:00 pmRNSResult of AGM
7th May 20257:00 amRNSAGM Statement and Q1 Trading Update
9th Apr 202510:00 amRNSDirectors' dealings
8th Apr 202510:00 amRNSDirectors' dealings
7th Apr 202510:00 amRNSDirectors’ dealings
4th Apr 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.